1. Home
  2. RNST vs BLTE Comparison

RNST vs BLTE Comparison

Compare RNST & BLTE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

RNST

Renasant Corporation

HOLD

Current Price

$41.19

Market Cap

3.5B

Sector

Finance

ML Signal

HOLD

Logo Belite Bio Inc

BLTE

Belite Bio Inc

HOLD

Current Price

$176.25

Market Cap

4.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RNST
BLTE
Founded
1904
2018
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.5B
4.1B
IPO Year
N/A
2022

Fundamental Metrics

Financial Performance
Metric
RNST
BLTE
Price
$41.19
$176.25
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
4
8
Target Price
$42.25
$161.57
AVG Volume (30 Days)
744.6K
232.2K
Earning Date
01-27-2026
03-16-2026
Dividend Yield
2.23%
N/A
EPS Growth
N/A
N/A
EPS
2.07
N/A
Revenue
$878,392,000.00
N/A
Revenue This Year
$31.72
N/A
Revenue Next Year
$4.58
N/A
P/E Ratio
$19.96
N/A
Revenue Growth
24.32
N/A
52 Week Low
$26.97
$49.00
52 Week High
$42.11
$200.00

Technical Indicators

Market Signals
Indicator
RNST
BLTE
Relative Strength Index (RSI) 69.93 58.49
Support Level $37.31 $175.18
Resistance Level $42.11 $192.94
Average True Range (ATR) 1.17 11.13
MACD 0.38 0.89
Stochastic Oscillator 85.38 48.27

Price Performance

Historical Comparison
RNST
BLTE

About RNST Renasant Corporation

Renasant Corp operates as a holding company for Renasant Bank, a Mississippi banking corporation, and its subsidiary, Renasant Insurance, Inc. It has three reportable segments: Community banks, Insurance, and Wealth management. With its Community banks segment, the company provides a range of financial services to individuals and small businesses. Its Insurance segment is an insurance agency providing commercial and personal insurance through third-party carriers. The Wealth management segment provides a range of services, including money management and retirement planning. The majority of the company's revenue is driven by lending activities in its community banks segment.

About BLTE Belite Bio Inc

Belite Bio Inc is a clinical-stage biopharmaceutical drug development company focused on novel therapeutics targeting untreatable eye diseases involving retinal degeneration such as atrophic age-related macular degeneration and autosomal recessive Stargardt disease or STGD1, both of which progressively to permanent blindness, and metabolic diseases such as non-alcoholic fatty liver disease, or NAFLD, nonalcoholic steatohepatitis, or NASH, type 2 diabetes, or T2D, and gout.

Share on Social Networks: